ALDEYRA THERAPEUTICS INC (ALDX)

US01438T1060 - Common Stock

3.93  -0.01 (-0.25%)

After market: 4.1 +0.17 (+4.33%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
42.79M62.68M56.22M34.67M56.50M
Research and Development
29.46M47.31M44.94M24.68M44.35M
Selling, General, and Administrative Expenses
13.34M15.37M11.28M9.99M12.15M
Operating Income
-42.79M-62.68M-56.22M-34.67M-56.50M
Interest Income/Expense
5.25M660.00K-1.56M-1.61M940.00K
Non Recurring Items
N/AN/A0.00-1.75M-6.57M
Income Before Taxes
-37.54M-62.02M-57.78M-38.03M-62.14M
Income Tax
N/AN/A0.00-480.00K-1.31M
Net Income
-37.54M-62.02M-57.78M-37.55M-60.83M
EBITDA
-42.53M-62.42M-55.96M-34.61M-56.40M
 
Per Share Data
EPS Diluted Total Ops
-0.64-1.06-1.07-1.11-2.24
Non GAAP EPS
-0.64-1.06-1.07-1.12-2.23
 
Statistics

All data in USD

Charts